(Q46111876)

19 December 2017

title

Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas (English)

1 reference

19 December 2017

author

Martin Walter

4

1 reference

19 December 2017

author name string

Simona Grozinsky-Glasberg

1

1 reference

19 December 2017

Dganit Barak

2

1 reference

19 December 2017

Merav Fraenkel

3

1 reference

19 December 2017

Jan Müeller-Brand

5

1 reference

19 December 2017

Joseph Eckstein

6

1 reference

19 December 2017

Liat Applebaum

7

1 reference

19 December 2017

Ilan Shimon

8

1 reference

19 December 2017

David J Gross

9

1 reference

19 December 2017

language of work or name

English

0 references

publication date

8 November 2010

1 reference

19 December 2017

published in

Cancer

1 reference

19 December 2017

volume

117

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

page(s)

1377-1385

1 reference

19 December 2017

Gastrinoma (duodenal and pancreatic).

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Endocrine tumors of the gut and pancreas tumor biology and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Control of the Zollinger-Ellison syndrome by excision of primary and metastatic tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

50-year appraisal of gastrinoma: recommendations for staging and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Endocrine tumours of the gastrointestinal tract: Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Endocrine tumours of the gastrointestinal tract. Management of metastatic endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Salvage therapy with (177)Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

Gastrinoma excision for cure. A prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

inferred from DOI database lookup

7 January 2021

based on heuristic

The gastrinoma triangle: operative implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

inferred from DOI database lookup

7 January 2021

based on heuristic

Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25646

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.25646

1 reference

19 December 2017

1 reference

19 December 2017